| Financial Year |
March 31 2023 |
| Monetary Funds |
793,211,598.81 |
| Held-for-trading Financial Assets |
1,142,357,001.17 |
| Notes Receivable |
-- |
| Accounts Receivable |
6,138,773.84 |
| Advances to Suppliers |
129,372,975.12 |
| Other Receivables |
2,854,031.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
191,539,520.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,510,764.04 |
| Total Current Assets |
2,420,145,753.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
124,429,565.71 |
| Investment Properties |
125,328,868.24 |
| Fixed Assetes |
163,191,163.82 |
| Under-construction Projects |
219,425,862.83 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
72,638,491.99 |
| R&D expenses |
-- |
| Goodwill |
226,277,154.96 |
| Long-Term Deferred and Prepaid Expenses |
212,584.25 |
| Deferred Income Tax Assets |
8,632,661.86 |
| Other Non-Current Assets |
21,688,678.57 |
| Sub-Total of Non-Current Assets |
1,184,425,032.23 |
| Total Assets |
3,604,570,785.63 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
31,613,341.74 |
| Accounts Payable |
183,985,758.64 |
| Accounts Received In Advance |
1,823,844.53 |
| Employee Compensation Payable |
15,977,518.29 |
| Taxes Payable |
39,001,902.46 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,375,820.37 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
94,451,998.25 |
| Other Current Liabilities |
54,344,884.91 |
| Sub-Total of Current Liabilities |
1,062,248,822.25 |
| Long-term Loans |
50,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,611,720.12 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
96,710,194.48 |
| Total Liabilities |
1,158,959,016.73 |
| Paid-In Capital(Or Share Stock) |
319,007,265.00 |
| Capital Surplus |
839,836,140.00 |
| Surplus Reserve |
135,795,001.23 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,051,448,686.77 |
| Minority Stockholder's Interest |
62,435,692.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,383,176,076.29 |
| Owner's Equity（Stockholder's Equity） |
2,445,611,768.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,604,570,785.63 |
